EQUINE STEM CELL SUPPORTIVE THERAPY SERVICES

Scientific Publications

  • Miljan EA., (2015) The business of stem cells research tools. In: Stem Cells in Regenerative Medicine, 1st Edition, John Wiley & Sons, pages 149-170.
  • Green CJ, Johnson D, Amin HD, Sivathondan P, Silva MA, Wang LM, Stevanato L, McNeil CA, Miljan EA, Sinden JD, Morten KJ, Hodson L. (2015) Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line. Am J Physiol Endocrinol Metab. Sep 15;309(6):E511-22
  • Katare R, Stroemer P, Hicks C, Stevanato L, Patel S, Corteling R, Miljan EA, Vishnubhatla I, Sinden J and Madeddu P. (2014) Clinical-grade human neural stem cells promote reparative neovascularization in mouse models of hindlimb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology, Feb;34(2):408-18
  • Volz KS, Miljan EA, Khooa A, Cooke JP. (2012) Development of pluripotent stem cells for vascular therapy. Vascular Pharmacology, May-Jun;56(5-6):288-96.
  • Muir KW, Sinden JD, Miljan EA, and Dunn L. (2011) Intracranial Delivery of Stem Cells. Transl. Stroke Res. 2:266–271 DOI 10.1007/s12975-011-0095-z
  • Hasan SM, Vugler AA, Miljan EA, Sinden JD, Keegan DJ, Moss SE and Greenwood J. (2010) Immortalised human foetal retinal cells retain progenitor characteristics and represent a potential source for the treatment of retinal degenerative disease. Cell Transplant. ;19(10):1291-306. Epub 2010 May 4.
  • Miljan EA and Sinden JD. (2009) Stem cell treatment of ischemic brain injury. Curr Opion Mol Therapeutics, 11(4):394-403.
  • Stevanato L, Corteling R, Stroemer P, Hope A, Miljan EA, Sinden JD. (2009) In vivo c-mycER transgene silencing in a genetically modified human neural stem cell line grafted in rodent brain. BMC Neuroscience, 10:86 doi:10.1186/1471-2202-10-86.
  • Thomas RJ, Hope A, Hourd P, Bradez M, Miljan EA, Sinden JD, Williams DJ. (2009) Automated serum free production of CTX0E03: a therapeutic clinical grade human neural stem cell line. Biotechnology Letters, DOI 10.1007/s10529-009-9989-1.
  • Aftab U, Jiang C, Tucker B, Kim JY, Klassen H, Miljan EA, Sinden JD, Young M. (2009) Growth kinetics and transplantation of human retinal progenitor cells. Exp. Eye Res, 89: 301-310.
  • Schmitt S, Aftab U, Jiang C, Redenti S, Klassen H, Miljan EA, Sinden JD, Young M. (2009) Molecular Characterization of Human Retinal Progenitor Cells. Investigative Ophthalmology & Visual Science (12):5901-8.
  • Miljan EA, Hines S, Pande P, Corteling RL, Hicks C, Zbarsky V, Umachandran M, Sowinski P, Richardson S, Tang E, Wieruszew M, Patel S, Stroemer P, Sinden JD. (2009) Implantation of c-mycER immortalized human mesencephalic derived clonal neural stem cell lines ameliorates behaviour dysfunction in a rat model of Parkinson’s Disease. Stem Cells and Development 18(2): 307-320.
  • Miljan EA (2008) In vitro modelling of Parkinson’s disease using ReNcell® VM human neural stem cell line. Cellutions 2:1-2.
  • Wood-Kaczmar A, Gandhi S, Yao Z, Miljan EA, Keen G, Stanyer L, Hargreaves I, Abramov AY, Duchen M, Klupsch K, Downward J, Mansfield L, Jat P, Latchman D, Taylor J, Heales S, Tabrizi SJ, Wood NJ. (2008) PINK1 is necessary for long term survival and mitochondrial function in primary human dopaminergic neurons. PLoS ONE 3:6;e2455.
  • Miljan EA (2007) ReNcell VM and CX: Renewable and consistent supply of human functional neurons. Cellutions 1:1-2.
  • Miljan EA (2007) Pioneering stem cell therapeutics: ReNeuron celebrates its 10th Anniversary. Re.News 03:6-16.
  • Donato R, Miljan EA, Hines SJ, Aouabdi S, Pollock K, Patel S, Edwards FA, Sinden JD (2007) Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neuroscience 8:36.
  • Pollock K, Stroemer P, Patel S, Stevanato L, Hope A, Miljan E, Dong Z, Hodges H, Price J, Sinden JD (2006) A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp Neurol 199:143-155.
  • Wilmut I, Allsopp T, Daniels R, Miljan EA, Prescott C, Przyborski S, Smith M, Waldby C, Walker J, Whittle, N. (2006) An assessment of regenerative medicine and stem cell technology - a mission to Australia. Global watch mission report, Department of Trade and Industry, United Kingdom, Published by Pera URN 07/501.
  • Hoffrogge R, Mikkat S, Scharf C, Beyer S, Christoph H, Pahnke J, Mix E, Berth M, Uhrmacher A, Zubrzycki IZ, Miljan E, Volker U, Rolfs A (2006) 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 6:1833-1847.
  • Miljan EA, Chu V, (2006) ReNcell VM and CX: Human Neural Stem Cell Lines – Characterization and Functional differentiation. Stem Cellutions 2:1-3.
  • Kozlowski DA, Miljan EA, Bremer EG, Harrod CG, Gerin C, Connor B, George D, Larson B, Bohn MC (2004) Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat. Brain Res 1016:170-181.
  • Krause A, Zacharias W, Camarata T, Linkhart B, Law E, Lischke A, Miljan E, Simon HG (2004) Tbx5 and Tbx4 transcription factors interact with a new chicken PDZ-LIM protein in limb and heart development. Dev Biol 273:106-120.
  • Miljan EA, Bremer EG (2002) Review: Regulation of growth factor receptors by gangliosides. Science STKE 298:1509, RE15.
  • Miljan EA, Meuillet EJ, Mania-Farnell B, George D, Yamamoto H, Simon HG, Bremer EG (2002) Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J Biol Chem 277:10108-10113.
  • Mayanil CS, George D, Freilich L, Miljan EA, Mania-Farnell B, McLone DG, Bremer EG (2001) Microarray analysis detects novel Pax3 downstream target genes. J Biol Chem 276:49299-49309.